600160:SSEZhejiang Juhua Co., Ltd. Class A Analysis
Data as of 2026-07-30 - not real-time
CN¥40.04
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Zhejiang Juhua trades at CNY 40.04, sitting below its 20‑day (42.08) and 50‑day (42.50) simple moving averages while remaining above the 200‑day average (38.14), indicating a short‑term pull‑back in a longer‑term uptrend. The MACD is bearish (line –1.51 vs signal –1.14) and volume is on a downtrend, suggesting limited upside momentum in the near term. Volatility is elevated at 74 % over the past 30 days and the beta is near zero, implying the stock moves independently of broader market swings. Valuation metrics show a trailing P/E of 26 versus a forward P/E of 16.9, and a DCF‑derived fair value of only CNY 25.3, flagging the stock as materially overvalued at current levels. Fundamentally, the company posts a solid ROE of 21 % and a healthy operating margin (26 %), but free cash flow is negative (‑CNY 1.0 bn) and the price‑to‑book ratio sits at 5×, reinforcing the overvaluation view.
Despite these pricing pressures, the firm delivers a 1.43 % dividend yield with a modest payout ratio of 27 %, indicating dividend sustainability. Revenue growth is modest (3.7 %) and the balance sheet is manageable with a debt‑to‑equity of 30.6 %. The business benefits from diversified end‑markets—including new‑energy and electronics—providing a stable long‑run demand backdrop. With a strong ROE, reasonable leverage, and a consistent dividend, the stock’s long‑term fundamentals remain attractive should the market price converge toward its intrinsic value.
Despite these pricing pressures, the firm delivers a 1.43 % dividend yield with a modest payout ratio of 27 %, indicating dividend sustainability. Revenue growth is modest (3.7 %) and the balance sheet is manageable with a debt‑to‑equity of 30.6 %. The business benefits from diversified end‑markets—including new‑energy and electronics—providing a stable long‑run demand backdrop. With a strong ROE, reasonable leverage, and a consistent dividend, the stock’s long‑term fundamentals remain attractive should the market price converge toward its intrinsic value.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD and price below short‑term SMAs
- Decreasing volume and high short‑term volatility
- Current price still above near‑term support (36.78)
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Forward P/E of 16.9 signals earnings upside
- Strong ROE and sustainable dividend yield
- Overvaluation relative to DCF fair value
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Robust operating margins and diversified end‑markets
- Solid cash‑flow generation despite short‑term negative free cash flow
- Potential price correction toward DCF valuation
Key Metrics & Analysis
Financial Health
Revenue Growth3.70%
Profit Margin15.26%
P/E Ratio26.0
ROE21.05%
ROA10.49%
Debt/Equity30.61
P/B Ratio5.0
Op. Cash FlowCN¥6.7B
Free Cash FlowCN¥-1036169792
Technical Analysis
TrendNeutral
RSI44.6
SupportCN¥36.78
ResistanceCN¥54.68
MA 20CN¥42.08
MA 50CN¥42.50
MA 200CN¥38.14
MACDBearish
VolumeDecreasing
Fear & Greed Index84.54
Valuation
Fair ValueCN¥25.29
GradeOvervalued
TypeBlend
Dividend Yield1.43%
Risk Assessment
Beta-0.04
Volatility74.32%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.